TheEdgeResearch
Home / Stocks / EWPI

Emerging World Pharma, Inc. (EWPI)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$11,930
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-5.45
52-Wk Range
0.000001-0.0001
CEO
Terry Agrivos
Country
GH
Currency
USD

Emerging World Pharma, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Sunyani, BA, GH. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $11,930. Its beta of -5.45 implies it has historically moved less than the broad market.

Company profile
Exchange
Other OTC
Employees
0
IPO date
2000-03-29
Headquarters
Sunyani, BA, GH
About Emerging World Pharma, Inc.

Emerging World Pharma, Inc. dedicates its resources to pharmaceutical enterprises that produce generic medications, specifically those operating within developing economies. The firm provides these companies with crucial manufacturing infrastructure, manages the hiring and skill-building of local personnel, and supplies necessary raw components. Their investment strategy is concentrated on pharmaceutical businesses that have secured agreements with religious organizations, various non-governmental groups, governmental bodies, and wholesale distributors. The company, established in 1997 with its base in Sunyani, Ghana, underwent a name change from Tubearoo, Inc. to Emerging World Pharma, Inc. in November 2009.

Comparable companies

Emerging World Pharma, Inc. is most often compared with the following Healthcare names:

ALDAAWWIBCAPECDDHALLIKTOKCMHLNTOOHCSVNTN
More research on EWPI
EWPI technical analysis EWPI TheEdge Score Compare against peers
Open full interactive analysis & DCF →